FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313473500> ?p ?o ?g. }

• W4313473500 endingPage "90" @default.
• W4313473500 startingPage "90" @default.
• W4313473500 abstract "While the prevalence of metabolic syndrome (MetS) is steadily increasing worldwide, no optimal pharmacotherapy is readily available to address its multifaceted risk factors and halt its complications. This growing challenge mandates the development of other future curative directions. The purpose of the present study is to investigate the efficacy of cranberry proanthocyanidins (PACs) in improving MetS pathological conditions and liver complications; C57BL/6J mice were fed either a standard chow or a high fat/high sucrose (HFHS) diet with and without PACs (200 mg/kg), delivered by daily gavage for 12 weeks. Our results show that PACs lowered HFHS-induced obesity, insulin resistance, and hyperlipidemia. In conjunction, PACs lessened circulatory markers of oxidative stress (OxS) and inflammation. Similarly, the anti-oxidative and anti-inflammatory capacities of PACs were noted in the liver in association with improved hepatic steatosis. Inhibition of lipogenesis and stimulation of beta-oxidation could account for PACs-mediated decline of fatty liver as evidenced not only by the expression of rate-limiting enzymes but also by the status of AMPKα (the key sensor of cellular energy) and the powerful transcription factors (PPARα, PGC1α, SREBP1c, ChREBP). Likewise, treatment with PACs resulted in the downregulation of critical enzymes of liver gluconeogenesis, a process contributing to increased rates of glucose production in type 2 diabetes. Our findings demonstrate that PACs prevented obesity and improved insulin resistance likely via suppression of OxS and inflammation while diminishing hyperlipidemia and fatty liver disease, as clear evidence for their strength of fighting the cluster of MetS abnormalities." @default.
• W4313473500 created "2023-01-06" @default.
• W4313473500 creator A5000579424 @default.
• W4313473500 creator A5004278412 @default.
• W4313473500 creator A5007009282 @default.
• W4313473500 creator A5007226750 @default.
• W4313473500 creator A5008313325 @default.
• W4313473500 creator A5020808506 @default.
• W4313473500 creator A5025613015 @default.
• W4313473500 creator A5028274475 @default.
• W4313473500 creator A5031307686 @default.
• W4313473500 creator A5031993900 @default.
• W4313473500 creator A5037076604 @default.
• W4313473500 creator A5044096349 @default.
• W4313473500 creator A5047467312 @default.
• W4313473500 date "2022-12-30" @default.
• W4313473500 modified "2023-10-17" @default.
• W4313473500 title "Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders" @default.
• W4313473500 cites W1534360145 @default.
• W4313473500 cites W1657478053 @default.
• W4313473500 cites W1914622032 @default.
• W4313473500 cites W1966872601 @default.
• W4313473500 cites W1971005475 @default.
• W4313473500 cites W1972709924 @default.
• W4313473500 cites W1983972216 @default.
• W4313473500 cites W1985800972 @default.
• W4313473500 cites W1989907045 @default.
• W4313473500 cites W1991265255 @default.
• W4313473500 cites W2003138919 @default.
• W4313473500 cites W2007876572 @default.
• W4313473500 cites W2011336591 @default.
• W4313473500 cites W2012037560 @default.
• W4313473500 cites W2024020128 @default.
• W4313473500 cites W2028250360 @default.
• W4313473500 cites W2033907196 @default.
• W4313473500 cites W2034640340 @default.
• W4313473500 cites W2059069430 @default.
• W4313473500 cites W2060388798 @default.
• W4313473500 cites W2061429720 @default.
• W4313473500 cites W2067850907 @default.
• W4313473500 cites W2080047236 @default.
• W4313473500 cites W2083547817 @default.
• W4313473500 cites W2094166298 @default.
• W4313473500 cites W2099456560 @default.
• W4313473500 cites W2121568629 @default.
• W4313473500 cites W2121782557 @default.
• W4313473500 cites W2139450675 @default.
• W4313473500 cites W2140930790 @default.
• W4313473500 cites W2143642040 @default.
• W4313473500 cites W2156339883 @default.
• W4313473500 cites W2162382402 @default.
• W4313473500 cites W2164561653 @default.
• W4313473500 cites W2178910175 @default.
• W4313473500 cites W2284659436 @default.
• W4313473500 cites W2290466312 @default.
• W4313473500 cites W2492051419 @default.
• W4313473500 cites W2501756334 @default.
• W4313473500 cites W2519048160 @default.
• W4313473500 cites W2534555913 @default.
• W4313473500 cites W2561255988 @default.
• W4313473500 cites W2566147975 @default.
• W4313473500 cites W2588383443 @default.
• W4313473500 cites W2612266291 @default.
• W4313473500 cites W2734724639 @default.
• W4313473500 cites W2765599500 @default.
• W4313473500 cites W2770328734 @default.
• W4313473500 cites W2794083325 @default.
• W4313473500 cites W2887429059 @default.
• W4313473500 cites W2921012991 @default.
• W4313473500 cites W2944172415 @default.
• W4313473500 cites W2948172128 @default.
• W4313473500 cites W2982680484 @default.
• W4313473500 cites W2990154620 @default.
• W4313473500 cites W3005249288 @default.
• W4313473500 cites W3013994080 @default.
• W4313473500 cites W3047012230 @default.
• W4313473500 cites W3093343778 @default.
• W4313473500 cites W3113060573 @default.
• W4313473500 cites W3122226502 @default.
• W4313473500 cites W3130053451 @default.
• W4313473500 cites W3130793612 @default.
• W4313473500 cites W3158919838 @default.
• W4313473500 cites W3176733419 @default.
• W4313473500 cites W3197212947 @default.
• W4313473500 cites W3215327329 @default.
• W4313473500 cites W4210347219 @default.
• W4313473500 cites W4230280576 @default.
• W4313473500 cites W4288010199 @default.
• W4313473500 doi "https://doi.org/10.3390/antiox12010090" @default.
• W4313473500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36670951" @default.
• W4313473500 hasPublicationYear "2022" @default.
• W4313473500 type Work @default.
• W4313473500 citedByCount "3" @default.
• W4313473500 countsByYear W43134735002023 @default.
• W4313473500 crossrefType "journal-article" @default.
• W4313473500 hasAuthorship W4313473500A5000579424 @default.
• W4313473500 hasAuthorship W4313473500A5004278412 @default.
• W4313473500 hasAuthorship W4313473500A5007009282 @default.

• next